Zalicus

245 First Street

Cambridge, MA  02142

Tel: 617.301.7000


Leadership:
Mark H.N. Corrigan, M.D.
President & CEO


Website:
www.zalicus.com

Zalicus

Flagship Partners:  Doug Cole
Initial Investment: 
2002
Status: 
Public

Zalicus, formerly CombinatoRx, discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. The Company applies its selective ion-channel modulation platform and its combination high throughput screening capabilities to discover innovative therapeutics for both internal product pipeline and its collaborators.